期刊
ARCHIVES OF NEUROLOGY
卷 59, 期 1, 页码 35-40出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archneur.59.1.35
关键词
-
The blood-brain barrier (BBB) is maintained by the endothelial tight junctions within the brain microvasculature. Most small-molecule neuropharmaceutical agents and virtually all large-molecule drugs do not cross the BBB. The BBB problem is the rate-limiting factor preventing the transfer of progress in the molecular neurosciences to the development of clinically effective neuro therapeutic agents. The future development of neurotherapeutic agents will be accelerated by the development of BBB drug-targeting technology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据